These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34081824)

  • 1. In vivo CRISPR-Cas9 knockout screening using quantitative PCR identifies thymosin beta-4 X-linked that promotes diffuse-type gastric cancer metastasis.
    An HW; Kim SY; Kwon JW; Seok SH; Woo SH; Kim DY; Park JW
    Mol Carcinog; 2021 Sep; 60(9):597-606. PubMed ID: 34081824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice.
    Park JW; Kim MS; Voon DC; Kim SJ; Bae J; Mun DG; Ko SI; Kim HK; Lee SW; Kim DY
    Mol Carcinog; 2018 Jul; 57(7):947-954. PubMed ID: 29528141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
    Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
    Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS.
    Zhuo W; Liu Y; Li S; Guo D; Sun Q; Jin J; Rao X; Li M; Sun M; Jiang M; Xu Y; Teng L; Jin Y; Si J; Liu W; Kang Y; Zhou T
    Gastroenterology; 2019 Feb; 156(3):676-691.e11. PubMed ID: 30445010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer.
    Oze I; Shimada S; Nagasaki H; Akiyama Y; Watanabe M; Yatabe Y; Matsuo K; Yuasa Y
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):551-554. PubMed ID: 27909811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescent Fibroblasts Potentiate Peritoneal Metastasis of Diffuse-type Gastric Cancer Cells
    Li Y; Tazawa H; Nagai Y; Fujita S; Okura T; Shoji R; Yamada M; Kikuchi S; Kuroda S; Ohara T; Noma K; Nishizaki M; Kagawa S; Fujiwara T
    Anticancer Res; 2024 Jun; 44(6):2497-2509. PubMed ID: 38821603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model.
    Rotkrua P; Shimada S; Mogushi K; Akiyama Y; Tanaka H; Yuasa Y
    Br J Cancer; 2013 Mar; 108(4):932-40. PubMed ID: 23385731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperativity of E-cadherin and Smad4 loss to promote diffuse-type gastric adenocarcinoma and metastasis.
    Park JW; Jang SH; Park DM; Lim NJ; Deng C; Kim DY; Green JE; Kim HK
    Mol Cancer Res; 2014 Aug; 12(8):1088-99. PubMed ID: 24784840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray.
    Wu CM; Lee YS; Wang TH; Lee LY; Kong WH; Chen ES; Wei ML; Liang Y; Hwang TL
    Oncol Rep; 2006 Jan; 15(1):57-64. PubMed ID: 16328034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer.
    Kanda M; Shimizu D; Sawaki K; Nakamura S; Umeda S; Miwa T; Tanaka H; Tanaka C; Hayashi M; Iguchi Y; Yamada S; Katsuno M; Kodera Y
    Mol Cancer; 2020 Aug; 19(1):131. PubMed ID: 32847597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGP9.5 methylation in diffuse-type gastric cancer.
    Yamashita K; Park HL; Kim MS; Osada M; Tokumaru Y; Inoue H; Mori M; Sidransky D
    Cancer Res; 2006 Apr; 66(7):3921-7. PubMed ID: 16585221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models.
    Shimada S; Akiyama Y; Mogushi K; Ishigami-Yuasa M; Kagechika H; Nagasaki H; Fukamachi H; Yuasa Y; Tanaka S
    Br J Cancer; 2018 Apr; 118(7):972-984. PubMed ID: 29527007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Helicobacter pylori and diffuse type gastric cancer.
    Handa Y; Saitoh T; Kawaguchi M; Misaka R; Ohno H; Tsai CR; Tani Y; Tsurui M; Yoshida H; Morita S; Midorikawa S; Sanji T
    J Gastroenterol; 1996 Nov; 31 Suppl 9():29-32. PubMed ID: 8959514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
    Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
    Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer.
    Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K
    World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EXOC4 Promotes Diffuse-Type Gastric Cancer Metastasis via Activating FAK Signal.
    Li H; Fu X; Zhao J; Li C; Li L; Xia P; Guo J; Wei W; Zeng R; Wu J; Sun Y; Huang L; Wang X
    Mol Cancer Res; 2022 Jul; 20(7):1021-1034. PubMed ID: 35471457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer.
    Choi JH; Kim YB; Ahn JM; Kim MJ; Bae WJ; Han SU; Woo HG; Lee D
    Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29622765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL1-Chemokine (C-X-C Motif) Receptor 2 Signaling Stimulates the Recruitment of Bone Marrow-Derived Mesenchymal Cells into Diffuse-Type Gastric Cancer Stroma.
    Kasashima H; Yashiro M; Nakamae H; Kitayama K; Masuda G; Kinoshita H; Fukuoka T; Hasegawa T; Nakane T; Hino M; Hirakawa K; Ohira M
    Am J Pathol; 2016 Nov; 186(11):3028-3039. PubMed ID: 27742059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.